Trofinetide Shows Promise in Rett Syndrome

(MedPage Today) -- The investigational drug trofinetide showed modest benefit in girls and young women with Rett syndrome, the phase III LAVENDER study showed. After 12 weeks of treatment, significant differences in two co-primary endpoints and...
Source: MedPage Today Neurology - Category: Neurology Source Type: news